ATE243762T1 - Gensonden und verfahren zum nachweis vom menschlichen immunschwäche-virus typ 1 - Google Patents

Gensonden und verfahren zum nachweis vom menschlichen immunschwäche-virus typ 1

Info

Publication number
ATE243762T1
ATE243762T1 AT94302196T AT94302196T ATE243762T1 AT E243762 T1 ATE243762 T1 AT E243762T1 AT 94302196 T AT94302196 T AT 94302196T AT 94302196 T AT94302196 T AT 94302196T AT E243762 T1 ATE243762 T1 AT E243762T1
Authority
AT
Austria
Prior art keywords
hiv
nucleic acid
virus type
methods
detecting human
Prior art date
Application number
AT94302196T
Other languages
English (en)
Inventor
Sherrol H Mcdonough
Thomas B Ryder
Yeasing Yang
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Application granted granted Critical
Publication of ATE243762T1 publication Critical patent/ATE243762T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94302196T 1993-03-26 1994-03-28 Gensonden und verfahren zum nachweis vom menschlichen immunschwäche-virus typ 1 ATE243762T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4074593A 1993-03-26 1993-03-26

Publications (1)

Publication Number Publication Date
ATE243762T1 true ATE243762T1 (de) 2003-07-15

Family

ID=21912702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94302196T ATE243762T1 (de) 1993-03-26 1994-03-28 Gensonden und verfahren zum nachweis vom menschlichen immunschwäche-virus typ 1

Country Status (9)

Country Link
US (2) US6252059B1 (de)
EP (2) EP0617132B1 (de)
JP (1) JP4108118B2 (de)
KR (1) KR100325554B1 (de)
AT (1) ATE243762T1 (de)
AU (1) AU686616B2 (de)
CA (1) CA2159103C (de)
DE (1) DE69432838T2 (de)
WO (1) WO1994023069A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
US5733781A (en) * 1994-07-19 1998-03-31 Gen-Probe Incorporated Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0796347A2 (de) * 1995-09-21 1997-09-24 Becton, Dickinson and Company Nachweis von nukleinsäure in zelle unter verwendung von thermophilen strangverdrängungsamplifikation
DE19644248A1 (de) * 1996-10-24 1998-04-30 Boehringer Mannheim Gmbh Primer und Probes zum Nachweis von HIV
US6025133A (en) * 1996-12-30 2000-02-15 Gen-Probe Incorporated Promoter-sequestered oligonucleoside and method of use
CA2222769C (en) * 1997-01-17 2001-06-12 F. Hoffmann-La Roche Ag Primers for the detection of hiv-1
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
ES2479065T3 (es) 1997-08-08 2014-07-23 Biomérieux Bv Métodos de uso de secuencias de ácido nucleico como cebadores y sondas en la amplificación y detección de todos los subtipos de VIH-1
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US7244570B2 (en) 1998-08-04 2007-07-17 Luminex Molecular Diagnostics, Inc. Methods and compositions for modulating “marginally indiscriminant” hybridizations
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 改変hivenvポリペプチド
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
AU3219400A (en) 1999-02-03 2000-08-25 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and reagents for molecular detection of hiv-1 groups m, n and
US6821770B1 (en) * 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
WO2001004361A2 (en) 1999-07-09 2001-01-18 Gen-Probe Incorporated Detection of hiv-1 by nucleic acid amplification
CA2392218A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
US6800463B1 (en) 2000-04-20 2004-10-05 Virco Bvba Method for mutation detection in HIV-1 using pol sequencing
WO2001081624A1 (en) * 2000-04-20 2001-11-01 Virco Bvba Method for mutation detection in hiv using pol sequencing
EP2020450B9 (de) * 2000-09-01 2011-09-14 Gen-Probe Incorporated HIV-1-Sequenzverstärkung zur Erkennung von Sequenzen in Zusammenhang mit Wirkstoffresistenz-Mutationen
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US6753145B2 (en) * 2001-07-05 2004-06-22 Agilent Technologies, Inc. Buffer composition and method for hybridization of microarrays on adsorbed polymer siliceous surfaces
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
WO2003020876A2 (en) 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US7132236B2 (en) * 2001-10-25 2006-11-07 Agilent Technologies, Inc. Composition and method for optimized hybridization using modified solutions
WO2005061735A2 (en) * 2003-12-04 2005-07-07 The Government Of The United States Of America As Represented By The Department Of Health Human Servicees Strand-specific amplification
EP1694871B1 (de) 2003-12-19 2010-08-25 Gen-Probe Incorporated Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
CN1910289B (zh) * 2004-01-07 2012-05-23 日立化成研究中心公司 用于检测hiv的引物和探针
FR2869045A1 (fr) * 2004-04-16 2005-10-21 Bioalliance Pharma Sa Methode d'etude de la variabilite genetique et fonctionnelle du vih et kit pour sa mise en oeuvre
EP1602736A1 (de) * 2004-06-04 2005-12-07 Bio-Rad Pasteur Detektion von HIV Typen und Subtypen
EP1800126B1 (de) * 2004-09-08 2014-12-17 The United States of America as represented by the Secretary of Health and Human Services, NIH Zusammensetzungen und verfahren für den nachweis von hiv-1/hiv-2-infektionen
WO2006099255A2 (en) 2005-03-10 2006-09-21 Gen-Probe Incorporated Systems and methods to perform assays for detecting or quantifying analytes within samples
EP2348320B1 (de) 2005-03-10 2024-05-01 Gen-Probe Incorporated Verfahren und Systeme zur Erkennung mehrerer Fluoreszenzemissionssignale
JPWO2007055260A1 (ja) * 2005-11-11 2009-04-30 財団法人ヒューマンサイエンス振興財団 人免疫不全ウイルス−1遺伝子検出又は定量用材料,検出又は定量方法,治療用遺伝子断片,及び治療方法
RU2350650C2 (ru) * 2006-04-17 2009-03-27 Общество с ограниченной ответственностью "Биосинтез" (ООО "Биосинтез") РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pVar15-HIV-LTR, НЕСУЩАЯ КЛОНИРОВАННЫЙ ФРАГМЕНТ ГЕНОМА ВИЧ-1 ТИПА ИЗ КОНСЕРВАТИВНОГО УЧАСТКА 5'-LTR ПОСЛЕДОВАТЕЛЬНОСТИ, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBluKSM-HIV-LTR mod, НЕСУЩАЯ КЛОНИРОВАННЫЙ МОДИФИЦИРОВАННЫЙ ФРАГМЕНТ ЭТОГО ЖЕ УЧАСТКА ГЕНОМА ВИЧ-1 ТИПА, ТЕСТ-НАБОР ДЛЯ КОЛИЧЕСТВЕННОЙ ЭКСПРЕСС-ИДЕНТИФИКАЦИИ ГЕНОМА ВИЧ-1 ЛЮБОГО ТИПА В ПРОБЕ И СПОСОБ С ЕГО ИСПОЛЬЗОВАНИЕМ
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
JP2010521156A (ja) * 2007-03-16 2010-06-24 454 ライフ サイエンシーズ コーポレイション Hiv薬物耐性バリアントの検出のためのシステムおよび方法
ITRM20070254A1 (it) * 2007-05-03 2008-11-04 Univ Palermo Metodo per la genotipizzazione di hiv-1 e relativi kit diagnostici per la rilevazione di farmaco-resistenze.
WO2009017743A2 (en) * 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
GB0814570D0 (en) 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US20120135397A1 (en) * 2009-07-07 2012-05-31 Tan Tock Seng Hospital Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
WO2012123591A1 (en) * 2011-03-17 2012-09-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for targeting nucleic acids to the nucleus
US9139870B2 (en) 2012-08-30 2015-09-22 Gen-Probe Incorporated Multiphase nucleic acid amplification
EP3068907A4 (de) * 2013-11-14 2017-06-14 The General Hospital Corporation Gegen hiv-reservoirs gerichtete suizidkontrastmittel für theranostische tilgung
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE131052T1 (de) 1983-01-10 1987-03-19 Gen-Probe Partners, San Diego, Calif. Verfahren zum aufspueren, identifizieren und quantifizieren von organismen und viren.
US9328391B1 (en) 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
CA1341423C (en) 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US4754065A (en) * 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
DE3785658T2 (de) 1986-08-11 1993-08-12 Siska Diagnostics Inc Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
US5079351A (en) 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
WO1989004375A1 (en) 1987-10-23 1989-05-18 Siska Diagnostics, Inc. Lanthanide chelate-tagged nucleic acid probes
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
CA2002076A1 (en) 1988-11-21 1990-05-21 Brent A. Burdick Diagnostic kit and method using a solid phase capture means for detecting nucleic acids
KR0148265B1 (ko) 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 자가-지속 서열 복제 시스템
JPH0638758B2 (ja) 1989-02-03 1994-05-25 イーストマン コダック カンパニー 核酸試験片及び所定の核酸を検出するためのその使用
EP1715064B1 (de) * 1989-06-02 2009-02-25 Institut Pasteur Nukleotid-Sequenzen von HIV-1, HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur Amplifizierung von pol-Sequenzen dieser Retroviren und zur In Vitro Diagnostik von diesen Viren verursachten Infektionen
EP0731175A3 (de) * 1989-07-11 2004-05-26 Gen-Probe Incorporated Oligonukleotid-Sonden für Nukleinsäure von HIV
US5856088A (en) 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
DE69029740T2 (de) * 1989-11-30 1997-07-10 Pharmacia Biotech Ab Neues verfahren zum nachweis einer spezifischen nukleinsäuresequenz in einer zellprobe
CA2032203C (en) 1989-12-29 2009-05-19 Christine L. Brakel Amplification capture assay
CA2070632A1 (en) * 1990-01-10 1991-07-11 Bayer Corporation Use of dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
US5427930A (en) * 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
FR2663949A1 (fr) * 1990-06-29 1992-01-03 Genset Sa Perfectionnements a un procede d'amplification enzymatique in vitro.
DK0540693T3 (da) * 1990-07-24 1999-09-13 Hoffmann La Roche Reduktion af ikke-specifik amplifikation under in vitro-nukleinsyreamplifikation under anvendelse af modificerede nukleinsy
JPH0491790A (ja) * 1990-08-02 1992-03-25 Shionogi & Co Ltd 2段階pcr法
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
ES2081613T3 (es) * 1991-03-21 1996-03-16 Johnson & Johnson Clin Diag Elemento y procedimiento para amplificacion y deteccion de acido nucleico usando muestras adheridas.
CA2065719A1 (en) * 1991-04-30 1992-10-31 John B. Findlay Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
FR2677039B1 (fr) * 1991-05-31 1994-09-09 Cis Bio Int Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
CA2110489A1 (en) * 1991-06-14 1992-12-23 Enzo Paoletti Immunodeficiency virus recombinant poxvirus vaccine
EP0519338B1 (de) * 1991-06-20 1996-08-28 F. Hoffmann-La Roche Ag Verbesserte Methoden zur Nukleinsäure-Amplifizierung
GB9116042D0 (en) * 1991-07-24 1991-09-11 Royal Free Hosp School Med Diagnostic method
ES2214472T3 (es) * 1991-08-02 2004-09-16 Biomerieux B.V. Cuantificacion de acidos nucleicos.
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
CA2124797C (en) * 1991-12-23 2004-03-30 Bruce D. Irvine Hiv probes for use in solution phase sandwich hybridization assays
JPH08500005A (ja) 1992-03-27 1996-01-09 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ 非感染性hiv粒子およびその用途
EP0642589A4 (de) 1992-05-11 1997-05-21 Ribozyme Pharm Inc Methode und reagenz zur inhibierung der viralen replikation.
ES2048652B1 (es) * 1992-06-05 1994-10-01 Inst De Salud Carlos Iii Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
US5366885A (en) 1992-06-09 1994-11-22 Barranco Iii Sam C Method and kit for testing tumors for drug sensitivity
WO1994003635A1 (en) * 1992-08-04 1994-02-17 Institute Of Molecular Biology & Biotechnology Rapid amplification and detection of nucleic acids
EP0591914B2 (de) * 1992-10-06 2010-02-10 Siemens Healthcare Diagnostics Products GmbH Retrovirus aus der HIV-Gruppe und dessen Verwendung

Also Published As

Publication number Publication date
EP0617132B1 (de) 2003-06-25
WO1994023069A1 (en) 1994-10-13
KR100325554B1 (ko) 2002-11-02
US6252059B1 (en) 2001-06-26
DE69432838D1 (de) 2003-07-31
AU686616B2 (en) 1998-02-12
US6649749B2 (en) 2003-11-18
EP1344837A1 (de) 2003-09-17
AU6551594A (en) 1994-10-24
JP4108118B2 (ja) 2008-06-25
US20020062016A1 (en) 2002-05-23
JPH08508404A (ja) 1996-09-10
CA2159103C (en) 2002-03-12
EP0617132A2 (de) 1994-09-28
KR960701219A (ko) 1996-02-24
CA2159103A1 (en) 1994-10-13
EP0617132A3 (en) 1995-11-29
DE69432838T2 (de) 2004-05-13

Similar Documents

Publication Publication Date Title
ATE243762T1 (de) Gensonden und verfahren zum nachweis vom menschlichen immunschwäche-virus typ 1
ATE237698T1 (de) Primers und sonden zum nachweis von hiv
US5389512A (en) Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
Abbott et al. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro
ATE185379T1 (de) Nukleotid-sequenzen des genoms von retroviren vom typ hiv-1, hiv-2 und siv, ihre verwendungen zur amplifikation dieser genome und in-vitro-diagnose dieser viralen infektionen
Silver et al. An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions
US5589333A (en) In situ polymerase chain reaction
ATE282720T1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
RU2186112C2 (ru) Олигонуклеотидный праймер, пара праймеров, набор праймеров (варианты), способ их изготовления для амплификации нуклеиновой кислоты вич-1
Nycz et al. Quantitative reverse transcription strand displacement amplification: quantitation of nucleic acids using an isothermal amplification technique
Karageorgos et al. Stepwise analysis of reverse transcription in a cell-to-cell human immunodeficiency virus infection model: kinetics and implications
Jurriaans et al. Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals
WO2000046403A3 (en) Methods and reagents for molecular detection of hiv-1 groups m, n and o
EP0481215A1 (de) Verfahren zum Nachweis von einem HIV-I-Genom durch ein zweistufiges PCR-Verfahren und dazu verwendete Oligonukleotide
Kostrikis et al. Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA)
WO1993025707A2 (es) Procedimientos de amplificacion de genoma y mezclas de oligonucleotidos iniciadores para la deteccion y la identificacion de secuencias genomicas relacionadas
Teglbjærg et al. Sensitive non-radioactive detection of HIV-1: use of nested primers for the amplification of HIV DNA
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
Dolana et al. Construction of gag, pol, and env specific riboprobes for confirmation of HIV-1 specific polymerase chain reaction products
Dolan et al. Construction of gag, pol, and env specific riboprobes for confirmation of HIV-1 specific polymerase chain reaction products
González-Villaseñor et al. A solid phase plate assay for HIV-1 genotyping

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties